Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThomas Powles, Petros Grivas, Haralabos P. Kalofonos et al.|New England Journal of Medicine|2020Cited by 1.5k
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-UpThomas Powles, Petros Grivas, Se Hoon Park et al.|Journal of Clinical Oncology|2023Cited by 210
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trialThomas Powles, Craig B. Davis, Srikala S. Sridhar et al.|Nature Medicine|2021Cited by 115